SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Health Services Pricing

The price dilemma over a $16,000 drug | Fox Business

The price dilemma over a $16,000 drug | Fox Business

If the drug does pan out with regulators, Novartis would have to drastically cut its price to make it competitive with other cardiovascular drugs. That would mean jettisoning a small, but reliable, revenue stream on an uncertain bet that the drug could become a top seller as a cardiovascular medicine. “They’ve got a bit of […]

Why education, healthcare and some other things cost ten times more than they used to and ten times more than elsewhere | NextBigFuture.com

Why education, healthcare and some other things cost ten times more than they used to and ten times more than elsewhere | NextBigFuture.com

Andrew Swift identifies the areas where people are willing to be scammed or are vulnerable. What you observe is fifty years of optimization of wealth extraction. Price outcomes depend on the contributions of hundreds of participants. Every participant optimizes his/her earnings, exerting a constant upward pressure on price. Participants become ever more expert at getting […]

Blue Cross Launches SmartShopper tool for comparing healthcare | brproud.com

Blue Cross Launches SmartShopper tool for comparing healthcare | brproud.com

Blue Cross Blue Shield of Louisiana customers who are ages 18 or older, with the exception of those covered through the Federal Employee Program, can access Smart Shopper. The tool is also available to Blue Cross network providers. “As healthcare costs keep rising, our members want greater transparency so they better understand the price differences […]

7 pressing healthcare topics CFOs should watch closely | Becker’s Hospital Review

7 pressing healthcare topics CFOs should watch closely | Becker’s Hospital Review

Mark Grube, Managing Director and National Strategy Leader, Software, Kaufman Hall: “Pricing strategy. We did a survey last year of health systems — we had roughly 120 respondents — on consumerism. We measured four different elements: patient experience, access considerations, using customer insights to drive strategy, and pricing. It was fascinating because in terms of […]

Can Drug Price Reductions Help or Hinder Pfizer Inc. ? | Library for Smart Investors (LFSI)

Can Drug Price Reductions Help or Hinder Pfizer Inc. ? | Library for Smart Investors (LFSI)

Pfizer Inc. (NYSE:PFE) so far has not joined the price reduction party and of course this has investors of the Interfaith Center on Corporate Responsibility (ICCR) worried. The news of Pfizer Inc.’s (NYSE:PFE) recent price hack made headlines earlier this month. The company jacked up the prices of 91 drugs by about a staggering 20%. […]

Pfizer investors slam new price increases as ‘out of step’ with its Big Pharma rivals | FiercePharma

Pfizer investors slam new price increases as ‘out of step’ with its Big Pharma rivals | FiercePharma

A host of Big Pharmas have either promised to limit their price hikes or opened up info on their increases and rebates. But Pfizer isn’t one of them—and that has some investors riled. In the wake of a new round of price hikes reported by the Financial Times, investor members of the Interfaith Center on […]

Value-based contracts key to solving U.S. drug pricing ‘crisis’ | Modern Healthcare

Value-based contracts key to solving U.S. drug pricing ‘crisis’ | Modern Healthcare

In one of the deals between the two, Harvard Pilgrim pays Eli Lilly a lower price for its Type 2 diabetes drug Trulicity if patients do better on competing diabetes drugs. We’re “putting our money where are mouth is—not just making claims about superiority, but measuring outcomes,” Ricks explained. The two CEOs see the value-based […]

Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica

Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica

Some pharmaceutical companies are troubled by stratospheric drug prices. Several have vowed to limit price hikes, for instance. And the powerful drug lobbying group PhRMA is at least trying to distract consumers’ attention away from price gouging by dangling shiny advertisements about their life-saving research. But there are some companies that just don’t care. Mylan […]

CSRxP launches campaign in Colorado to hold big pharma accountable for out-of-control drug prices | Rocky Mountain Post

CSRxP launches campaign in Colorado to hold big pharma accountable for out-of-control drug prices | Rocky Mountain Post

The Campaign for Sustainable Rx Pricing (CSRxP), a broad-based coalition of leaders from every sector in healthcare, launched a campaign in Colorado and nationally as part of a multi-million-dollar effort to hold Big Pharma accountable for the rising prices of prescription drugs. Because Big Pharma blocks competition to maintain monopolies on medicines, they can set any price they […]

FDA Commissioner Hints at Drug Pricing-Related Initiatives | Health Law & Policy Matters

FDA Commissioner Hints at Drug Pricing-Related Initiatives | Health Law & Policy Matters

During his first appearance before Congress as FDA Commissioner on May 25, 2017, Scott Gottlieb reported that the Agency is preparing a “Drug Competition Action Plan” that it will unveil in upcoming weeks and months. This was likely welcome news to many politicians from both parties, as well as to President Trump, who has publicly shamed pharmaceutical […]